Lantern Pharma, Inc. (LTRN)

3.38 -0.12 (-3.43%) USD  |  NASDAQ  |  May 26, 16:00
3.31 -0.07 (-2.07%) Pre-Market: 09:16
More

Lantern Pharma Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for LTRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
BioVie, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Spero Therapeutics, Inc. Upgrade
Replimune Group, Inc. Upgrade
Acurx Pharmaceuticals, Inc. Upgrade